EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 273 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $80,012 | -57.4% | 23,533 | +47.9% | 0.00% | – |
Q4 2022 | $187,933 | -34.3% | 15,913 | +16.9% | 0.00% | – |
Q3 2022 | $286,000 | -72.5% | 13,616 | -59.4% | 0.00% | -100.0% |
Q2 2022 | $1,040,000 | -53.6% | 33,500 | -38.6% | 0.00% | 0.0% |
Q1 2022 | $2,239,000 | -16.8% | 54,523 | -11.9% | 0.00% | 0.0% |
Q4 2021 | $2,691,000 | -22.2% | 61,912 | -10.4% | 0.00% | -50.0% |
Q3 2021 | $3,461,000 | +119.5% | 69,115 | +176.1% | 0.00% | +100.0% |
Q2 2021 | $1,577,000 | -56.4% | 25,030 | -35.7% | 0.00% | -50.0% |
Q1 2021 | $3,619,000 | +6.4% | 38,955 | +2.6% | 0.00% | -33.3% |
Q4 2020 | $3,402,000 | -6.4% | 37,971 | +7.9% | 0.00% | 0.0% |
Q3 2020 | $3,635,000 | -2.6% | 35,176 | -25.5% | 0.00% | -25.0% |
Q2 2020 | $3,732,000 | +29.3% | 47,195 | -5.4% | 0.00% | +33.3% |
Q1 2020 | $2,887,000 | +46.0% | 49,902 | +36.2% | 0.00% | +50.0% |
Q4 2019 | $1,977,000 | +1.3% | 36,637 | -1.8% | 0.00% | 0.0% |
Q3 2019 | $1,951,000 | +7.5% | 37,321 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $1,815,000 | -23.4% | 37,567 | -19.9% | 0.00% | -33.3% |
Q1 2019 | $2,369,000 | -18.1% | 46,886 | -3.9% | 0.00% | -25.0% |
Q4 2018 | $2,891,000 | +549.7% | 48,774 | +454.5% | 0.00% | +300.0% |
Q2 2018 | $445,000 | +15.9% | 8,796 | +20.5% | 0.00% | 0.0% |
Q1 2018 | $384,000 | +95.9% | 7,302 | +73.3% | 0.00% | – |
Q4 2017 | $196,000 | +12.0% | 4,213 | -2.6% | 0.00% | – |
Q3 2017 | $175,000 | -12.1% | 4,324 | -26.3% | 0.00% | -100.0% |
Q2 2017 | $199,000 | +20.6% | 5,870 | +2.8% | 0.00% | 0.0% |
Q1 2017 | $165,000 | +3.8% | 5,710 | +17.3% | 0.00% | 0.0% |
Q4 2016 | $159,000 | +34.7% | 4,866 | +29.6% | 0.00% | – |
Q3 2016 | $118,000 | -39.8% | 3,756 | -46.2% | 0.00% | -100.0% |
Q2 2016 | $196,000 | -29.0% | 6,978 | -8.2% | 0.00% | 0.0% |
Q1 2016 | $276,000 | -13.8% | 7,604 | -4.9% | 0.00% | 0.0% |
Q4 2015 | $320,000 | +34.5% | 7,998 | -4.2% | 0.00% | 0.0% |
Q3 2015 | $238,000 | +440.9% | 8,345 | +415.4% | 0.00% | – |
Q4 2014 | $44,000 | +33.3% | 1,619 | +5.5% | 0.00% | – |
Q3 2014 | $33,000 | +106.2% | 1,534 | +109.8% | 0.00% | – |
Q2 2014 | $16,000 | +1500.0% | 731 | +2607.4% | 0.00% | – |
Q1 2014 | $1,000 | – | 27 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
AtonRa Partners | 11,505 | $472,000 | 0.26% |